The evidence on peptides — delivered weekly. Subscribe free →

Cholecystokinin

low risk

Also: CCK · CCK-8 · Satiety hormone

Strong Evidence Research Only

Reference entry for cholecystokinin (CCK), the primary GI satiety hormone released from duodenal I-cells in response to fat and protein. Signals fullness via vagal afferents and hypothalamic CCK receptors. CCK-1 receptor agonism is a drug target for obesity.

Molecular Weight
1143.3 Da (CCK-8)
Formula
C49H62N10O13S
Common Dosing
Not used therapeutically in native form
Category
research
Last Reviewed
2025-01-15

Reported Benefits

Satiety signaling

Strong Evidence 340 studies

Well-characterized GI satiety hormone. CCK-1 receptor agonism is active drug target for obesity pharmacology.

Mechanism of Action

Released from duodenal I-cells post-meal; acts on CCK-1 (CCK-A) receptors on vagal afferents; stimulates pancreatic enzyme and bile secretion; inhibits gastric emptying; signals satiety to hypothalamus.

Relevance to Obesity Pharmacology

CCK-1 receptor agonists are an active target class for obesity drug development. Understanding native CCK physiology provides context for interpreting early-stage compounds targeting this pathway.

✦ Sponsored

Stop Guessing About Your Health. Start Optimizing It.

Advanced diagnostics and licensed medical providers delivering personalized longevity care to uncover root causes, optimize health, and track progress virtually or in person.

Learn More →
Nava Health

Regulatory Status

Research Only

Safety Profile

Side Effects

  • •Not applicable

Contraindications

  • •N/A

Primary Uses

Satiety signalingDigestive enzyme releaseGI motilityEducational reference

Related Peptides

SemaglutideGhrelinCagrilintide

Planning a protocol?

Use the AI Stack Builder to generate a phased schedule, compatibility analysis, and monitoring checklist.

Stack Builder → Protocol Builder →

Weekly Briefing

Regulatory updates + new study breakdowns.

For Practitioners

Do you prescribe Cholecystokinin?

Get in front of patients who've already researched this protocol and are ready to consult. Featured listings from $199/mo.

Get Listed →
Disclaimer: This information is for educational and research purposes only. Not medical advice. Consult a qualified healthcare provider before using any compound.